Beck Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Beck Capital Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,383	Closed	-$2.13M	–	123
2024 Q3	$2.13M	Buy	22,383 +1,109	+5%	+$105K	0.57%	67
2024 Q2	$1.95M	Buy	21,274 +317	+2%	+$28.3K	0.54%	67
2024 Q1	$1.9M	Buy	20,957 +897	+4%	+$78.5K	0.55%	65
2023 Q4	$1.63M	Buy	+20,060	New	+$1.57M	0.56%	68
2016 Q1	–	Sell	-3,931	Closed	-$257K	–	138
2015 Q4	$257K	Buy	+3,931	New	+$254K	0.15%	102

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return

MTWSIF

Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $789M AUM 73.25% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Beck Capital Management's PPH Position: Q4 2024 in Review

Beck Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 22,383 shares — an estimated $2.13M sold.

Beck Capital Management first reported a position in PPH in Q4 2015 and held it in 5 quarters. The position peaked at $2.13M in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

Beck Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
Beck Capital Management sold 22,383 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $2.13M.
Beck Capital Management first reported a position in VanEck Pharmaceutical ETF in Q4 2015 and held it in 5 quarters.
Beck Capital Management's VanEck Pharmaceutical ETF position peaked at $2.13M in Q3 2024.
142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Beck Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.